CLINICAL_TRIALS
research
· 2025-09-10
Clinical Trial Update: Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT [Phase 3]
Summary
A Phase III randomized trial is evaluating upfront cranial radiotherapy versus observation in patients with oncogene-mutated non-small cell lung cancer and asym…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tata Memorial Hospital | Conditions: Asymptomatic Brain Metastases, Driver Mutation Positive Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING